Navigation Links
SPO Reports Results for Second Quarter 2013

NEW YORK, August 20, 2013 /PRNewswire/ --

SPO (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced recently its financial results for the fiscal quarter ended June 30, 2013.

Total revenue for first half 2013 was $249,000 compared to no revenues for the same period in 2012. In addition the Company has a current backlog of approximately $249,000 of purchase orders which it intends to deliver during 3rd quarter 2013. The revenue increase was attributed to shipments of our new consumer wellness product to mass market retailers. Since August 2012, we have partnered with HoMedics LLC for distribution of our private-labeled pulse oximeter known as the HoMedics Deluxe Pulse Oximeter.

Furthermore, the Company announced that it has commenced commercialization of its new consumer wellness time-piece designed to measure overall daily activity levels, especially useful for the estimated 100 million obese adults & children in the US. The Company is working closely with its distribution partner to realize this retail opportunity commencing late 2013 and beyond.

Michael Braunold, Chief Executive Officer of SPO commented: "We are pleased with our continuing success, working with our partners HoMedics for retail distribution of our private-labeled pulse oximeter. Our new wellness watch will also be available for sale shortly, and we look forward to capitalizing on both these revenue opportunities in the coming quarters and into 2014. Adding this second product to our portfolio in a relatively short period of time has allowed us to further expand our strategy in the fast-growing consumer wellness market. In addition, we continue to work on other product opportunities, including a unique baby-monitor for parental reassurance when babies are sleeping and a sports watch to continuously measure heart-rate during exercise without the need of a chest strap."

The new wellness time-piece, designed both for children and adults, has innovative features including display functionality and a time-piece which continuously measures number of daily movements and calories burned against preset recommended goals. Furthermore, the watch is designed to encourage individuals to wear it with pride and to help towards improving their overall lifestyle.

Further details as to SPO's financial information and results of operations for the fiscal quarter ended June 30, 2013 are in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 8, 2013.

About SPO

SPO is a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-enhancing information within four key markets: medical care; sports and wellness; homecare monitoring and security. Its patented technology uses information gathered from the reflectance of light on the human body, in a noninvasive manner, to monitor key vital signs. The company manufactures its products in addition to licensing its technologies to appropriate client corporations for commercialization and distribution. For more information, visit

Forward Looking Statements

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, expectations as to the realization of additional revenues from the order backlog, expectations as to the timing and the commercial launch of our new consumer wellness timepiece as well as our efforts to expand distribution of products to additional mass market retailers, the ability to create additional strategic partnerships to aid in the distribution of products, expectations regarding the successful expansion of our product base to include, among other products, the baby monitor and the sports watch, profitability, market acceptance of our products and new product applications, timing of new product launches, success of the Company's rebranding program, product performance, size of prospective markets, revenue assessments, marketing strategies, success of our restructured operations and plans, our ability to generate fees or raise capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. We undertake no obligation to revise or update any forward-looking statement for any reason.

Contact regarding this release:

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global IVIG Market Report 2013 Edition Research at
2. Cellular Biomedicine Group Reports Second Quarter and First Half 2013 Financial Results and Business Highlights
3. AML Therapeutics Market in the 6MM Worth $430.7m in 2017 Says a New Research Report Available at
4. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
5. Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results
6. Organovo Reports Q1 Fiscal 2014 Results, Provides Business Update
7. Dyadic International Reports Second Quarter 2013 Financial Results
8. Microbes Market and Microbial Products Reviewed in New Research Report at
9. Discovery Labs Reports Second Quarter 2013 Financial Results
10. Global Crop Protection Chemicals Market Till 2016 - Worldwide Research Report, Industry Share, Size, Trends, Analysis, Growth and Forecast 2012-2016: MarketResearchReports
11. Z Trim Holdings Reports Sales Growth in July 2013 over July 2012
Post Your Comments:
(Date:11/23/2015)... -- Women with a certain type of lung nodule visible ... of lung cancer than men with similar nodules, according to ... meeting of the Radiological Society of North America ... --> Lung nodules are small masses of tissue in ... on their appearance on CT. Solid nodules are dense, and ...
(Date:11/23/2015)... ... November 23, 2015 , ... ... the development of its Nexera UC Unified Chromatography system. The award from R&D ... significant new products of the year in the analytical and testing category. R&D ...
(Date:11/23/2015)... PISCATAWAY, New Jersey , November ... Data Centre (CCDC) announces the launch of ... (CSD) and the CSD-System, now complemented by three ... to support the discovery of new molecules, CSD-Materials ... the complete set of the CCDC,s applications incorporating ...
(Date:11/23/2015)... WASHINGTON , Nov. 23, 2015 ... research firm to exclusively serve the ... of its global strategic report, "Mesenchymal ... Published November 2015, it presents 250 ... mesenchymal stem cell (MSC) industry. ...
Breaking Biology Technology:
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
(Date:10/29/2015)... October 29, 2015 NXTD ... company focused on the growing mobile commerce market ... that StackCommerce, a leading marketplace to discover and ... Wocket® smart wallet on StackSocial for this holiday ... or the "Company"), a biometric authentication company focused ...
(Date:10/27/2015)... 2015 In the present market scenario, security ... various industry verticals such as banking, healthcare, defense, electronic ... demand for secure & simplified access control and growing ... hacking of bank accounts, misuse of users, , and ... PC,s, laptops, and smartphones are expected to provide potential ...
Breaking Biology News(10 mins):